HCA HCA Healthcare
NYSE · SEC CIK 860730 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $31.12M 6 sales by 5 insiders
- Filings on record
- 323 since 2021-07-23, latest 2026-08-28 13:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| HAZEN SAMUEL N | CEO, Dir | — | $21.48M |
| Berres Jennifer | SVP, Chief Human Res. Off | — | $4.13M |
| McAlevey Michael R | EVP, Chief Legal, Admin Off | — | $2.75M |
| Wyatt Christopher F. | SVP, Ctrl | — | $2.02M |
| Cuffe Michael S. | EVP, Chief Clinical Off | — | $747.1K |
| Rossitto Erica | SVP, Chief Nurse Executive | — | — |
| Marks Mike A | EVP, CFO | — | — |
| Smith Andrea B | Dir | — | — |
| Foster Jon M | EVP, COO | — | — |
| Frist William R | Dir, 10% | — | — |
Transactions 488
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | 2024-02-16 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | F - Tax | $308.55 | -3,240 | 18.7K | -15% | -$999.7K | |
| 2024-02-21 | 2024-02-16 | HCA | Marks Mike A | SVP-Fin | A - Grant | $0.00 | +3,780 | 3,825 | +8,400% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Marks Mike A | SVP-Fin | F - Tax | $308.55 | -1,022 | 2,803 | -27% | -$315.3K | |
| 2024-02-16 | 2024-02-14 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | G - Gift | $0.00 | -349 | 9,901 | -3% | $0 | |
| 2024-02-13 | 2024-02-09 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | S - Sale | $306.21 | -4,262 | 10.2K | -29% | -$1.31M | |
| D | 2024-02-08 | 2024-02-06 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | F - Tax | $306.82 | -1,423 | 20.3K | -7% | -$436.6K |
| D | 2024-02-08 | 2024-02-06 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | M - OptEx | $173.12 | +2,092 | 21.7K | +11% | +$362.2K |
| 2024-02-08 | 2024-02-06 | HCA | Akdamar Erol R | Group Pres | G - Gift | $0.00 | -12.9K | 0 | -100% | $0 | |
| I | 2024-02-08 | 2024-02-06 | HCA | Akdamar Erol R | Group Pres | G - Gift | $0.00 | +12.9K | 55.4K | +30% | $0 |
| 2024-02-07 | 2024-02-05 | HCA | Wyatt Christopher F. | SVP, Ctrl | S - Sale | $312.42 | -4,000 | 37.4K | -10% | -$1.25M | |
| DM | 2024-02-07 | 2024-02-05 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $82.82 | +8,550 | 16.8K | +104% | +$708.1K |
| D | 2024-02-07 | 2024-02-05 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $310.62 | -4,288 | 14.5K | -23% | -$1.33M |
| DM | 2024-02-06 | 2024-02-02+ | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | M - OptEx | $231.79 | +6,435 | 8,937 | +257% | +$1.49M |
| DM | 2024-02-06 | 2024-02-02+ | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | F - Tax | $309.42 | -5,161 | 9,188 | -36% | -$1.60M |
| D | 2024-02-06 | 2024-02-05 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | S - Sale+OE | $312.00 | -1,645 | 7,646 | -18% | -$513.2K |
| D | 2024-02-06 | 2024-02-02 | HCA | RUTHERFORD BILL B | CFO, EVP | F - Tax | $309.42 | -9,652 | 15.8K | -38% | -$2.99M |
| D | 2024-02-06 | 2024-02-06 | HCA | RUTHERFORD BILL B | CFO, EVP | S - Sale+OE | $310.63 | -6,000 | 8,448 | -42% | -$1.86M |
| DM | 2024-02-06 | 2024-02-05 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | -1,369 | 15.6K | -8% | $0 |
| DI | 2024-02-06 | 2024-02-05 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | +1,194 | 19.8K | +6% | $0 |
| D | 2024-02-06 | 2024-02-02 | HCA | RUTHERFORD BILL B | CFO, EVP | M - OptEx | $69.58 | +19.1K | 25.5K | +300% | +$1.33M |
| D | 2024-02-06 | 2024-02-02 | HCA | Wasserman Chad J | SVP, CIO | S - Sale+OE | $312.04 | -652 | 290.31 | -69% | -$203.5K |
| D | 2024-02-06 | 2024-02-03 | HCA | Wasserman Chad J | SVP, CIO | F - Tax | $309.42 | -38 | 379.31 | -9% | -$11.8K |
| D | 2024-02-06 | 2024-02-03 | HCA | Wasserman Chad J | SVP, CIO | M - OptEx | — | +127 | 417.31 | +44% | — |
| D | 2024-02-02 | 2024-01-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | G - Gift | $0.00 | -728 | 28.1K | -3% | $0 |
| D | 2024-02-02 | 2024-01-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale | $306.79 | -3,200 | 24.9K | -11% | -$981.7K |
| D | 2024-02-02 | 2024-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | F - Tax | $304.90 | -6,376 | 41.4K | -13% | -$1.94M |
| DM | 2024-02-02 | 2024-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $96.75 | +11.7K | 38.8K | +43% | +$1.13M |
| DM | 2024-02-02 | 2024-02-01 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | M - OptEx | $184.24 | +13.0K | 27.6K | +89% | +$2.39M |
| D | 2024-02-02 | 2024-01-31 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale+OE | $307.00 | -3,861 | 15.9K | -20% | -$1.19M |
| D | 2024-02-02 | 2024-02-01 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | F - Tax | $314.66 | -9,268 | 19.6K | -32% | -$2.92M |
| D | 2024-01-31 | 2024-01-29 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | M - OptEx | — | +323 | 8,113 | +4% | — |
| D | 2024-01-31 | 2024-01-29 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | F - Tax | $286.73 | -96 | 8,017 | -1% | -$27.5K |
| D | 2024-01-31 | 2024-01-29 | HCA | Hammett Richard A | Group Pres | M - OptEx | — | +600 | 14.4K | +4% | — |
| D | 2024-01-31 | 2024-01-29 | HCA | Hammett Richard A | Group Pres | F - Tax | $286.73 | -164 | 14.2K | -1% | -$47.0K |
| D | 2024-01-30 | 2024-01-28 | HCA | McAlevey Michael R | SVP, CLO | F - Tax | $283.43 | -489 | 4,012 | -11% | -$138.6K |
| D | 2024-01-30 | 2024-01-28 | HCA | McAlevey Michael R | SVP, CLO | M - OptEx | — | +1,940 | 4,501 | +76% | — |
| D | 2023-11-15 | 2023-11-13 | HCA | Akdamar Erol R | Group Pres | F - Tax | $229.99 | -14.0K | 12.9K | -52% | -$3.21M |
| D | 2023-11-15 | 2023-11-13 | HCA | Akdamar Erol R | Group Pres | M - OptEx | $47.97 | +26.8K | 26.8K | New | +$1.29M |
| D | 2023-11-14 | 2023-11-10 | HCA | Billington Phillip G | SVP-Internal Audit Services | F - Tax | $232.82 | -6,237 | 49.9K | -11% | -$1.45M |
| D | 2023-11-14 | 2023-11-10 | HCA | Billington Phillip G | SVP-Internal Audit Services | M - OptEx | $47.97 | +12.0K | 56.1K | +27% | +$576.8K |
| MI | 2023-11-14 | 2023-11-10+ | HCA | Sowell Joseph A III | SVP, Chief Development Off | G - Gift | $0.00 | +5,159 | 29.8K | +21% | $0 |
| 2023-11-14 | 2023-11-14 | HCA | Sowell Joseph A III | SVP, Chief Development Off | G - Gift | $0.00 | -5,159 | 0 | -100% | $0 | |
| MI | 2023-08-16 | 2023-08-14 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | +40.5K | 0 | New | $0 |
| 2023-08-16 | 2023-08-14 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | -40.5K | 6,369 | -86% | $0 | |
| 2023-08-16 | 2023-08-14 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale | $269.12 | -5,204 | 19.8K | -21% | -$1.40M | |
| 2023-08-15 | 2023-08-11 | HCA | Cohen Jeffrey E. | SVP-Government Relations | S - Sale | $270.00 | -1,500 | 4,414 | -25% | -$405.0K | |
| M | 2023-08-07 | 2023-08-03+ | HCA | Marks Mike A | SVP-Fin | G - Gift | $0.00 | -8,548 | 45 | -99% | $0 |
| I | 2023-08-07 | 2023-08-03 | HCA | Marks Mike A | SVP-Fin | G - Gift | $0.00 | +8,343 | 41.0K | +26% | $0 |
| 2023-08-07 | 2023-08-03 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | S - Sale | $270.00 | -2,916 | 10.2K | -22% | -$787.3K | |
| I | 2023-08-04 | 2023-08-02 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | +49.5K | 49.5K | New | $0 |
| 2023-08-04 | 2023-08-02 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | -49.5K | 46.9K | -51% | $0 | |
| M | 2023-08-03 | 2023-08-01 | HCA | Foster Jon M | EVP, COO | G - Gift | $0.00 | -11.4K | 11.5K | -50% | $0 |
| MI | 2023-08-03 | 2023-08-01 | HCA | Foster Jon M | EVP, COO | G - Gift | $0.00 | +11.4K | 55.1K | +26% | $0 |
| 2023-05-16 | 2023-05-12 | HCA | Hammett Richard A | Group Pres | G - Gift | $0.00 | -1,100 | 13.8K | -7% | $0 | |
| MI | 2023-05-08 | 2023-05-04 | HCA | HAZEN SAMUEL N | CEO, Dir | G - Gift | $0.00 | +12.5K | 7,864 | New | $0 |
| M | 2023-05-08 | 2023-05-04 | HCA | HAZEN SAMUEL N | CEO, Dir | G - Gift | $0.00 | -12.5K | 155.9K | -7% | $0 |
| 2023-05-02 | 2023-04-28 | HCA | Akdamar Erol R | Group Pres | S - Sale | $285.00 | -3,500 | 42.5K | -8% | -$997.5K | |
| 2023-05-02 | 2023-05-01 | HCA | Akdamar Erol R | Group Pres | G - Gift | $0.00 | -42.5K | 0 | -100% | $0 | |
| I | 2023-05-02 | 2023-05-01 | HCA | Akdamar Erol R | Group Pres | G - Gift | $0.00 | +42.5K | 42.5K | New | $0 |
| DM | 2023-05-02 | 2023-04-28 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | M - OptEx | $141.51 | +8,844 | 27.6K | +47% | +$1.25M |
| D | 2023-05-02 | 2023-04-28 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | F - Tax | $287.33 | -6,123 | 25.0K | -20% | -$1.76M |
| 2023-05-02 | 2023-04-28 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale | $284.44 | -12.6K | 28.8K | -30% | -$3.57M | |
| 2023-04-26 | 2023-04-24 | HCA | Frist William R | Dir, 10% | A - Grant | $0.00 | +1,047 | 10.9K | +11% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | FRIST THOMAS F III | Dir, 10% | A - Grant | $0.00 | +1,396 | 12.2K | +13% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | DEPARLE NANCY ANN | Dir | A - Grant | $0.00 | +663 | 20.1K | +3% | $0 | |
| D | 2023-04-26 | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $101.16 | +32.0K | 60.8K | +111% | +$3.24M |
| D | 2023-04-26 | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $286.25 | -19.5K | 41.3K | -32% | -$5.57M |
| 2023-04-26 | 2023-04-24 | HCA | Dennis Robert J | Dir | A - Grant | $0.00 | +1,047 | 24.6K | +4% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | Johnston Hugh F | Dir | A - Grant | $0.00 | +663 | 2,030 | +49% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | Riley Wayne Joseph | Dir | A - Grant | $0.00 | +663 | 13.3K | +5% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | MICHELSON MICHAEL W | Dir | A - Grant | $0.00 | +1,187 | 9,387 | +14% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale | $288.38 | -4,473 | 22.2K | -17% | -$1.29M | |
| 2023-04-26 | 2023-04-24 | HCA | Smith Andrea B | Dir | A - Grant | $0.00 | +663 | 2,902 | +30% | $0 | |
| 2023-04-26 | 2023-04-24 | HCA | CROFTON MEG | Dir | A - Grant | $0.00 | +663 | 5,721 | +13% | $0 | |
| D | 2023-04-14 | 2023-04-12 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $81.96 | +6,340 | 31.0K | +26% | +$519.6K |
| D | 2023-04-14 | 2023-04-14 | HCA | Paslick P. Martin | SVP, CIO | S - Sale+OE | $275.00 | -2,687 | 24.6K | -10% | -$738.9K |
| D | 2023-04-14 | 2023-04-12 | HCA | Paslick P. Martin | SVP, CIO | F - Tax | $272.38 | -3,653 | 27.3K | -12% | -$995.0K |
| 2023-04-12 | 2023-04-10 | HCA | Paslick P. Martin | SVP, CIO | S - Sale | $270.00 | -2,539 | 24.6K | -9% | -$685.5K | |
| D | 2023-04-06 | 2023-04-05 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $81.96 | +6,000 | 30.6K | +24% | +$491.8K |
| D | 2023-04-06 | 2023-04-05 | HCA | Paslick P. Martin | SVP, CIO | F - Tax | $271.31 | -3,461 | 27.2K | -11% | -$939.0K |
| D | 2023-04-06 | 2023-04-04 | HCA | Paslick P. Martin | SVP, CIO | S - Sale+OE | $265.00 | -3,034 | 24.6K | -11% | -$804.0K |
| 2023-02-22 | 2023-02-17 | HCA | HAZEN SAMUEL N | CEO, Dir | A - Grant | $0.00 | +94.9K | 200.6K | +90% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | HAZEN SAMUEL N | CEO, Dir | F - Tax | $262.84 | -36.8K | 163.8K | -18% | -$9.66M | |
| 2023-02-22 | 2023-02-17 | HCA | Foster Jon M | EVP, COO | A - Grant | $0.00 | +19.7K | 30.7K | +180% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Foster Jon M | EVP, COO | F - Tax | $262.84 | -7,768 | 22.9K | -25% | -$2.04M | |
| 2023-02-22 | 2023-02-17 | HCA | Sowell Joseph A III | SVP, Chief Development Off | A - Grant | $0.00 | +7,600 | 7,600 | New | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Sowell Joseph A III | SVP, Chief Development Off | F - Tax | $262.84 | -2,441 | 5,159 | -32% | -$641.6K | |
| 2023-02-22 | 2023-02-17 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | A - Grant | $0.00 | +6,080 | 28.6K | +27% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | F - Tax | $262.84 | -1,844 | 26.7K | -6% | -$484.7K | |
| 2023-02-22 | 2023-02-17 | HCA | RUTHERFORD BILL B | CFO, EVP | A - Grant | $0.00 | +24.3K | 105.9K | +30% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | RUTHERFORD BILL B | CFO, EVP | F - Tax | $262.84 | -9,563 | 96.4K | -9% | -$2.51M | |
| 2023-02-22 | 2023-02-17 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $262.84 | -4,232 | 28.8K | -13% | -$1.11M | |
| 2023-02-22 | 2023-02-17 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | A - Grant | $0.00 | +12.2K | 33.0K | +58% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Cohen Jeffrey E. | SVP-Government Relations | F - Tax | $262.84 | -1,652 | 5,914 | -22% | -$434.2K | |
| 2023-02-22 | 2023-02-17 | HCA | Cohen Jeffrey E. | SVP-Government Relations | A - Grant | $0.00 | +4,560 | 7,566 | +152% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Akdamar Erol R | Group Pres | A - Grant | $0.00 | +9,300 | 49.1K | +23% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Akdamar Erol R | Group Pres | F - Tax | $262.84 | -3,110 | 46.0K | -6% | -$817.4K | |
| 2023-02-22 | 2023-02-17 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | F - Tax | $262.84 | -2,441 | 12.6K | -16% | -$641.6K | |
| 2023-02-22 | 2023-02-17 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | A - Grant | $0.00 | +7,600 | 15.0K | +103% | $0 | |
| 2023-02-22 | 2023-02-17 | HCA | Billington Phillip G | SVP-Internal Audit Services | A - Grant | $0.00 | +4,560 | 45.2K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations